Investigation of pd-l1 (cd274), pd-l2 (pdcd1lg2), and ctla-4 expressions in malignant pleural mesothelioma by immunohistochemistry and real-time polymerase chain reaction methods

Abstract

Read online

Keywords

• ctla-4
• immune checkpoints
• pd-l1 (cd274)
• pd-l2 (pdcd1lg2)
• programmed cell death ligand 1
• programmed cell death ligand 2
• malignant pleural mesothelioma